Scientists ‘solve’ puzzle of blood clots linked to AstraZeneca vaccine
Study suggests a protein in the blood is attracted to a key part of the vaccine
Scientists believe they have discovered why the Oxford/AstraZeneca Covid-19 vaccine may cause blood clots in a very small number of people.
A team of researchers from Cardiff and the US found that a protein in the blood is attracted to a key component of the vaccine, the BBC reported. This, they suggest, causes a chain reaction in the immune system that can culminate in dangerous clots.
Professor Alan Parker, one of the researchers at Cardiff University, said the side effect occurs only in extremely rare cases because of a chain of complex events in those individuals.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
His team found that the outer surface of the adenovirus used by AstraZeneca attracts the platelet factor four protein to it like a magnet.
Parker said: “The adenovirus has an extremely negative surface, and platelet factor four is extremely positive and the two things fit together quite well.”
He added that his team has been able to prove the link between the “key smoking guns of adenoviruses and platelet factor four”.
The scientists believe that the next stage of the process is “misplaced immunity”, but this needs to be confirmed in further research.
Sky News noted that the number of people affected is thought to be very small. In May, the UK’s medicines safety regulator said there had been 242 clotting cases and 49 deaths, with 28.5 million doses of the vaccine administered.
Nevertheless, concerns over rare blood clots have influenced how the vaccine has been deployed around the world. For example, the AstraZeneca jab was not offered to the under-40s in the UK and alternatives were used instead.
AstraZeneca claimed that clots were more likely to occur because of a Covid infection than the vaccine, and insisted that the complete explanation for why they occur had not yet been established.
Commenting on the findings, a spokeswoman for the company said the research is “not definitive” but “offers interesting insights”.
AstraZeneca added that the vaccine is thought to have saved more than a million lives around the world and prevented 50 million cases of Covid. The University of Oxford, which worked on the vaccine, declined to comment on the research.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Ottawa climate talks: can global plastic problem be solved?
In the spotlight Nations aim to draft world's first treaty on plastic pollution, but resistance from oil- and gas-producing countries could limit scope
By Harriet Marsden, The Week UK Published
-
Netherlands split on WFH for sex workers
Speed Read Councils concerned over 'nuisance' of at-home sex work, but others say changes will curb underground sex trade
By Arion McNicoll, The Week UK Published
-
'He adored Trump, and then rejected him'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published